BioAtla's market cap is currently ―. The company's EPS TTM is $-2.583; its P/E ratio is -1.11; BioAtla is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -26.93M	$ -33.33M	$ -35.75M	$ -28.94M	$ -28.59M
EBITDA	$ -26.56M	$ -33.05M	$ -35.46M	$ -28.65M	$ -28.29M
Net Income Common Stockholders	$ -26.93M	$ -33.33M	$ -35.75M	$ -27.46M	$ -27.54M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 111.47M	$ 141.28M	$ 168.69M	$ 192.69M	$ 215.51M
Total Assets	$ 119.66M	$ 151.36M	$ 179.64M	$ 204.55M	$ 225.74M
Total Debt	$ 2.46M	$ 2.85M	$ 3.23M	$ 3.61M	$ 3.98M
Net Debt	$ -109.01M	$ -138.44M	$ -165.46M	$ -189.08M	$ -211.53M
Total Liabilities	$ 48.99M	$ 56.66M	$ 55.12M	$ 48.13M	$ 45.40M
Stockholders Equity	$ 70.67M	$ 94.70M	$ 124.52M	$ 156.43M	$ 180.34M
Cash Flow	-
Free Cash Flow	$ -29.93M	$ -27.37M	$ -24.11M	$ -22.70M	$ -24.38M
Operating Cash Flow	$ -29.92M	$ -27.34M	$ -24.09M	$ -22.65M	$ -24.35M
Investing Cash Flow	$ -8.00K	$ -25.00K	$ -15.00K	$ -50.00K	$ -31.00K
Financing Cash Flow	$ 119.00K	$ -41.00K	$ 115.00K	$ -116.00K	$ 61.77M

Currency in USD

BioAtla Earnings and Revenue History

Income Statement >

BioAtla Debt to Assets

Balance Sheet >

BioAtla Cash Flow

Cash Flow >

BioAtla Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing